-- Parkland Brief: Simpson Oil Announcing Its Support For the Sunoco-Parkland Transaction-March 2024-www.financetom.com

-- Parkland Brief: Simpson Oil Announcing Its Support For the Sunoco-Parkland Transaction

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

-- Parkland Brief: Simpson Oil Announcing Its Support For the Sunoco-Parkland Transaction

Jun 6, 2025 1:25 PM

03:47 PM EDT, 06/06/2025 (MT Newswires) --

Price: 39.21, Change: +0.48, Percent Change: +1.24

Previous page： Snow Lake Resources Prices Common Stock Offering Next page： Viad to Change Name to Pursuit Attractions and Hospitality

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Snow Lake Resources Prices Common Stock Offering

Dec 19, 2024

09:59 AM EST, 12/19/2024 (MT Newswires) -- Snow Lake Resources ( LITM ) said Thursday it has priced a public offering of about 15.8 million common shares at $0.41 apiece for gross proceeds of about $6.5 million. Net proceeds from the offering, which will likely close Friday, will be allocated toward working capital and general corporate purposes, the company said....

Viad to Change Name to Pursuit Attractions and Hospitality

Dec 19, 2024

10:03 AM EST, 12/19/2024 (MT Newswires) -- Viad ( VVI ) said Thursday it will change its name to Pursuit Attractions and Hospitality, effective Dec. 31. The company said it will start trading under its new NYSE ticker PRSU on Jan. 2. The move follows the previously disclosed sale of Viad's ( VVI ) GES business, which is slated to...

Merck's HIV treatment meets main goal in two late-stage studies

Dec 19, 2024

Dec 19 (Reuters) - Merck's ( MRK ) experimental two-drug combination met the main goal of significantly suppressing replication of the HIV-1 virus in adults receiving another form of therapy in two late-stage studies, the company said on Thursday. The U.S. drugmaker is seeking new growth drivers to offset a potential hit from its blockbuster cancer immunotherapy Keytruda losing patent...

-- Triple Flag Brief: National Bank Reiterates Its Outperform rating As "Accounts for a diverse asset base and strong FCF generation"

Dec 19, 2024

09:58 AM EST, 12/19/2024 (MT Newswires) -- Price: 22.20, Change: -0.06, Percent Change: -0.27 ...